Funded Startups in Rockville
Among the 30 most recent Rockville-area rounds shown (2020-03-25 to 2025-11-27), XENERGY leads on disclosed size with a $700M Series D dated 2025-11-27, dw…
Among the 30 most recent Rockville-area rounds shown (2020-03-25 to 2025-11-27), XENERGY leads on disclosed size with a $700M Series D dated 2025-11-27, dwarfing the next-largest disclosed rounds in the $150M–$200M band (REGENXBIO $150M on 2025-05-19, Supernus Pharmaceuticals $150M on 2023-02-14, and AgNovos Bioscience $32M aside from that cluster). Several entries concentrate around the most recent quarters: 2025 alone runs from 2025-02-19 (Quantum Space, $60K) through 2025-11-27 (XENERGY), with a visible cluster of late-September and early-October financings (e.g., OncoC4 $50M on 2025-10-05 and HoloMD $2M on 2025-11-06). Stage labeling is frequently incomplete: 2025 includes at least one “Series Unknown” (e.g., PediaMetrix $2M on 2025-08-23) and multiple “undisclosed” amounts (e.g., US Fertility on 2025-11-25). Biotech appears repeatedly across the dataset, with multiple companies listed under biotechnology/pharmaceuticals spanning 2023–2025 (e.g., REGENXBIO 2025-05-19, CASI Pharmaceuticals 2024-06-26, TissueGene 2023-05-15).
Most recent rounds
30 shownRelated listings
Frequently asked
What’s the largest disclosed round in Rockville here, and how extreme is it versus the rest?
XENERGY’s $700M Series D on 2025-11-27 is a clear size outlier; the next-largest disclosed amounts shown are $200M (AccufyDx, 2025-09-30) and $150M (REGENXBIO, 2025-05-19; Supernus Pharmaceuticals, 2023-02-14), with most other disclosed rounds far below those levels.
Do the most recent financings cluster in time rather than being spread out evenly?
Yes. The dataset spans 2020-03-25 (Sepio Systems) to 2025-11-27 (XENERGY), and within 2025 there are multiple entries in quick succession around late September to early October, including OncoC4 $50M (2025-10-05), HoloMD $2M (2025-11-06), and XENERGY $700M (2025-11-27).
Which stage labels or disclosure patterns dominate, and what’s the impact on interpreting size?
“Undisclosed” appears multiple times (e.g., US Fertility on 2025-11-25; Authxperts LLC on 2025-10-02; MasPanadas on 2023-03-01), while “Series Unknown” also recurs (e.g., OS Therapies 2025-07-14 with $4M; PediaMetrix 2025-08-23 with $2M). This means disclosed comparisons are concentrated among the subset with explicit dollar amounts.
Are there sector concentrations, particularly around biotechnology/pharmaceuticals?
Biotechnology/pharmaceuticals shows up repeatedly across different years, including OncoC4 ($50M, 2025-10-05), REGENXBIO ($150M, 2025-05-19), CASI Pharmaceuticals ($15M, 2024-06-26), AgNovos Bioscience ($32M, 2023-06-09), and TissueGene ($30M, 2023-05-15), indicating a sustained biotech presence rather than a single-year spike.
Which entries sit near the bottom of disclosed amounts, and are they materially smaller than the rest?
Quantum Space’s $60K on 2025-02-19 is the smallest disclosed amount in the rows shown. Even within 2025, most other disclosed entries are in the $2M–$200M range (e.g., HoloMD $2M on 2025-11-06 and AccufyDx $200K is listed as $200K on 2025-09-30), making the low end notably compressed relative to the main disclosed clusters.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.